Brady A Campbell
Overview
Explore the profile of Brady A Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Habib J, Rompen I, Javed A, Campbell B, Kinny-Koster B, Tan P, et al.
Ann Surg
. 2025 Mar;
PMID: 40042799
Summary Of Background Data: Intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic cancer is typically managed like pancreatic intraepithelial neoplasia (PanIN)-derived pancreatic cancer. However, in IPMN-derived pancreatic cancer, the role of chemotherapy...
2.
Javed A, Habib J, Andel P, Campbell B, Rompen I, Mahmud O, et al.
Ann Surg
. 2025 Feb;
PMID: 39928537
Objective: The aim of the study was to investigate prognostic factors in context of neoadjuvant therapy (NAT) and develop tools that can allow for accurate and personalized patient prognostication. Summary...
3.
Ventin M, Arya S, Cattaneo G, Fernandez-Del Castillo C, Wei A, Zureikat A, et al.
Ann Surg
. 2025 Jan;
PMID: 39781747
Objective: To investigate the clinicopathological features and long-term outcomes of cystic and solid pancreatic neuroendocrine tumors (PanNETs). Summary Background Data: PanNETs uncommonly present as cystic lesions. Whether cystic PanNETs represent...
4.
Habib J, Javed A, Rompen I, Hidalgo Salinas C, Sorrentino A, Campbell B, et al.
Ann Surg Oncol
. 2025 Jan;
32(3):1911-1912.
PMID: 39755887
No abstract available.
5.
Habib J, Javed A, Rompen I, Hidalgo Salinas C, Sorrentino A, Campbell B, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):1879-1886.
PMID: 39666193
Background: Early recurrence in intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) is poorly defined. Predictors are lacking and needed for patient counseling, risk stratification, and postoperative management. This...
6.
Rompen I, Habib J, Kinny-Koster B, Campbell B, Stoop T, Kummerli C, et al.
Ann Surg
. 2024 Sep;
PMID: 39291382
Aim: To investigate the impact of total pancreatectomy (TP) on oncological outcomes for patients at high-risk of local recurrence or secondary progression in the remnant gland after partial pancreatectomy (PP)...
7.
Habib J, Rompen I, Kinny-Koster B, Campbell B, Andel P, Sacks G, et al.
Ann Surg
. 2024 Sep;
PMID: 39263741
Objective: To assess the prognostic impact of margin status in patients with resected intraductal papillary mucinous neoplasms (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) and to inform future intraoperative decision-making on handling...
8.
Habib J, Rompen I, Campbell B, Andel P, Kinny-Koster B, Damaseviciute R, et al.
J Natl Cancer Inst
. 2024 Jul;
116(11):1791-1797.
PMID: 39029923
Background: Intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) is resected at smaller sizes compared with its biologically distinct counterpart, pancreatic intraepithelial neoplasia (PanIN)-derived PDAC. Thus, experts proposed T1...
9.
Campbell B, Rozycki G, Haut E, Fang R, Hultman C
Am Surg
. 2021 Nov;
89(5):1431-1435.
PMID: 34841921
Background: The purpose of this study was to determine the differences in patient outcomes between motor vehicle crash (MVC) victims with an ISS < 15 and those with a similar...
10.
Andrews C, Campbell B, Elcock A
J Chem Theory Comput
. 2018 Nov;
14(12):6746-6747.
PMID: 30427668
No abstract available.